Nifty

:

11504.95

Sensex

:

38845.82

-11.15 (-0.10%)
-134.03 (-0.34%)

Login

Nifty
Sensex

:
:

11504.95
38845.82

-11.15 (-0.10%)
-134.03 (-0.34%)

Vivimed Labs Ltd.

Pharmaceuticals & Drugs

Rating :

50/99

BSE: 532660 | NSE: VIVIMEDLAB

Watchlist

NSE BSE

20.30

18-Sep-2020

Open
High
Low
Previous Close

20.30
20.60
20.10
19.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

266041
54.13
23.35
6.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

168.73
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,028.14
N/A
0.35

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.37
-0.96
-3.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.13
-5.31
-16.02

PAT CAGR (%)

10 Years
5 Years
3 Years

6.35
-4.45
-35.52

P:E (Median)

8 Years
5 Years
3 Years

5.05
4.08
2.97

P:BV (Average)

8 Years
5 Years
3 Years

0.86
0.76
0.40

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.62
7.26
7.97

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 53.53 59.11 -9.44% 55.10 74.60 -26.14% 62.77 51.72 21.37% 99.62 63.50 56.88%
Expenses 38.15 46.48 -17.92% 55.11 57.31 -3.84% 52.59 35.97 46.21% 90.14 46.53 93.72%
EBITDA 15.38 12.63 21.77% -0.01 17.29 - 10.18 15.75 -35.37% 9.49 16.97 -44.08%
EBIDTM 28.74% 21.37% -0.02% 23.17% 16.22% 30.45% 9.52% 26.73%
Other Income 1.36 2.63 -48.29% 1.59 7.64 -79.19% 1.31 0.17 670.59% 1.01 0.16 531.25%
Interest 11.40 9.97 14.34% 10.02 18.14 -44.76% 11.85 11.31 4.77% 11.15 11.57 -3.63%
Depreciation 3.94 4.29 -8.16% 3.92 4.70 -16.60% 4.17 4.31 -3.25% 4.19 4.42 -5.20%
PBT 1.40 1.00 40.00% -12.35 2.09 - -4.53 0.30 - -4.85 1.15 -
Tax 0.23 0.25 -8.00% -0.61 -0.42 - 0.00 -0.77 - -1.21 -0.09 -
PAT 1.17 0.75 56.00% -11.74 2.51 - -4.53 1.06 - -3.64 1.24 -
PATM 2.19% 1.27% -21.31% 3.37% -7.22% 2.06% -3.65% 1.95%
EPS 0.14 0.09 55.56% -1.42 0.30 - -0.55 0.13 - -0.44 0.15 -

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 322.79 344.21 -6.22% 235.82 348.08 -32.25% 197.70 243.93 -18.95% 281.07 364.62 -22.91%
Expenses 276.21 303.11 -8.87% 256.48 326.69 -21.49% 206.57 207.18 -0.29% 284.53 314.42 -9.51%
EBITDA 46.58 41.10 13.33% -20.66 21.39 - -8.87 36.74 - -3.46 50.20 -
EBIDTM 14.43% 11.94% -8.76% 6.14% -4.49% 15.06% -1.23% 13.77%
Other Income 1.81 1.27 42.52% 2.42 6.10 -60.33% 2.09 6.31 -66.88% 2.48 5.04 -50.79%
Interest 14.88 12.11 22.87% 14.71 12.83 14.65% 16.48 17.56 -6.15% 15.59 17.59 -11.37%
Depreciation 17.29 16.95 2.01% 17.48 16.05 8.91% 15.62 15.29 2.16% 16.90 19.58 -13.69%
PBT 16.22 13.31 21.86% -50.44 -1.40 - -38.88 10.21 - -33.47 18.07 -
Tax 3.38 3.16 6.96% 10.40 -1.41 - -6.80 -0.63 - -7.12 -0.21 -
PAT 12.84 10.15 26.50% -60.84 0.01 - -32.07 10.84 - -26.35 18.28 -
PATM 3.98% 2.95% -25.80% 0.00% -16.22% 4.44% -9.38% 5.01%
EPS 1.55 1.22 27.05% -7.34 0.00 - -3.87 1.31 - -3.18 2.21 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 271.02 251.81 261.39 569.84 319.39 430.15 431.99 423.13 382.90 309.81 210.59 Net Sales Growth 8.87% -3.67% -54.13% 78.42% -25.75% -0.43% 2.09% 10.51% 23.59% 47.12% Cost Of Goods Sold 142.50 80.30 86.40 179.93 131.55 197.90 234.65 239.81 227.73 194.39 126.00 Gross Profit 128.52 171.51 174.99 389.91 187.85 232.24 197.35 183.31 155.17 115.42 84.58 GP Margin 47.42% 68.11% 66.95% 68.42% 58.82% 53.99% 45.68% 43.32% 40.52% 37.26% 40.16% Total Expenditure 235.99 184.32 183.05 319.35 232.56 320.10 337.82 331.28 301.65 253.03 170.68 Power & Fuel Cost - 8.92 10.83 15.13 11.03 15.81 20.36 19.82 14.78 10.50 7.72 % Of Sales - 3.54% 4.14% 2.66% 3.45% 3.68% 4.71% 4.68% 3.86% 3.39% 3.67% Employee Cost - 37.88 34.09 42.23 23.99 27.88 19.83 15.51 10.58 10.54 10.20 % Of Sales - 15.04% 13.04% 7.41% 7.51% 6.48% 4.59% 3.67% 2.76% 3.40% 4.84% Manufacturing Exp. - 22.13 21.49 30.76 26.81 35.44 35.36 36.28 33.26 23.70 13.69 % Of Sales - 8.79% 8.22% 5.40% 8.39% 8.24% 8.19% 8.57% 8.69% 7.65% 6.50% General & Admin Exp. - 30.80 19.75 39.85 35.91 32.50 24.37 18.28 9.87 8.10 6.76 % Of Sales - 12.23% 7.56% 6.99% 11.24% 7.56% 5.64% 4.32% 2.58% 2.61% 3.21% Selling & Distn. Exp. - 4.28 5.28 3.21 3.27 3.61 3.25 1.57 5.42 4.37 3.57 % Of Sales - 1.70% 2.02% 0.56% 1.02% 0.84% 0.75% 0.37% 1.42% 1.41% 1.70% Miscellaneous Exp. - 0.01 5.21 8.23 0.00 6.94 0.00 0.00 0.00 1.42 3.57 % Of Sales - 0.00% 1.99% 1.44% 0% 1.61% 0% 0% 0% 0.46% 1.30% EBITDA 35.04 67.49 78.34 250.49 86.83 110.05 94.17 91.85 81.25 56.78 39.91 EBITDA Margin 12.93% 26.80% 29.97% 43.96% 27.19% 25.58% 21.80% 21.71% 21.22% 18.33% 18.95% Other Income 5.27 8.54 1.93 8.75 2.79 1.43 11.44 8.38 4.72 0.68 2.01 Interest 44.42 52.63 53.27 59.02 59.49 66.67 48.75 31.64 24.08 18.41 15.39 Depreciation 16.22 18.26 18.14 26.83 18.79 20.56 18.06 17.21 10.55 6.08 4.40 PBT -20.33 5.13 8.85 173.39 11.34 24.25 38.81 51.38 51.34 32.97 22.12 Tax -1.59 -1.05 -1.01 47.04 3.21 5.32 12.18 14.65 10.93 5.21 5.58 Tax Rate 7.82% -20.47% -11.41% 27.13% 28.31% 21.94% 31.38% 28.51% 21.29% 15.80% 25.23% PAT -18.74 6.19 9.87 126.34 8.13 18.93 26.63 36.73 40.41 27.76 16.54 PAT before Minority Interest -18.74 6.19 9.87 126.34 8.13 18.93 26.63 36.73 40.41 27.76 16.54 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -6.91% 2.46% 3.78% 22.17% 2.55% 4.40% 6.16% 8.68% 10.55% 8.96% 7.85% PAT Growth -437.05% -37.28% -92.19% 1,454.00% -57.05% -28.91% -27.50% -9.11% 45.57% 67.84% EPS -2.26 0.75 1.19 15.24 0.98 2.28 3.21 4.43 4.87 3.35 2.00

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 1,037.38 1,315.17 1,185.66 1,461.91 1,345.63 1,380.10 1,350.83 1,108.80 668.31 416.00 343.49 Net Sales Growth -20.25% 10.92% -18.90% 8.64% -2.50% 2.17% 21.83% 65.91% 60.65% 21.11% Cost Of Goods Sold 439.09 518.40 479.67 536.28 624.05 646.23 656.33 513.27 337.39 236.97 203.49 Gross Profit 598.29 796.77 705.99 925.63 721.58 733.88 694.51 595.52 330.93 179.03 140.00 GP Margin 57.67% 60.58% 59.54% 63.32% 53.62% 53.18% 51.41% 53.71% 49.52% 43.04% 40.76% Total Expenditure 1,023.79 1,146.24 984.93 1,057.46 1,122.68 1,158.21 1,166.29 928.00 538.02 329.44 279.13 Power & Fuel Cost - 42.77 34.73 34.78 38.26 46.70 51.39 44.06 22.33 11.08 8.28 % Of Sales - 3.25% 2.93% 2.38% 2.84% 3.38% 3.80% 3.97% 3.34% 2.66% 2.41% Employee Cost - 241.76 197.78 189.98 176.94 184.43 162.66 50.33 32.19 19.97 22.07 % Of Sales - 18.38% 16.68% 13.00% 13.15% 13.36% 12.04% 4.54% 4.82% 4.80% 6.43% Manufacturing Exp. - 217.39 176.69 175.06 167.31 179.26 182.37 230.50 91.61 32.06 19.82 % Of Sales - 16.53% 14.90% 11.97% 12.43% 12.99% 13.50% 20.79% 13.71% 7.71% 5.77% General & Admin Exp. - 111.52 78.75 93.93 95.26 76.30 86.64 69.34 31.42 15.96 15.29 % Of Sales - 8.48% 6.64% 6.43% 7.08% 5.53% 6.41% 6.25% 4.70% 3.84% 4.45% Selling & Distn. Exp. - 14.41 16.66 15.39 20.86 25.29 26.91 20.50 23.09 11.26 9.32 % Of Sales - 1.10% 1.41% 1.05% 1.55% 1.83% 1.99% 1.85% 3.45% 2.71% 2.71% Miscellaneous Exp. - 0.00 0.65 12.03 0.00 0.00 0.00 0.00 0.00 2.14 9.32 % Of Sales - 0% 0.05% 0.82% 0% 0% 0% 0% 0% 0.51% 0.25% EBITDA 13.59 168.93 200.73 404.45 222.95 221.89 184.54 180.80 130.29 86.56 64.36 EBITDA Margin 1.31% 12.84% 16.93% 27.67% 16.57% 16.08% 13.66% 16.31% 19.50% 20.81% 18.74% Other Income 8.80 33.97 23.76 8.09 23.63 8.02 35.90 26.33 2.68 1.00 6.84 Interest 61.66 70.06 82.35 67.79 85.26 86.20 67.46 50.44 28.37 22.10 22.82 Depreciation 67.29 66.79 56.42 58.28 61.39 66.18 66.12 58.81 26.79 10.20 8.73 PBT -106.57 66.05 85.71 286.48 99.93 77.54 86.86 97.88 77.82 55.26 39.65 Tax -0.14 8.68 9.62 72.50 16.26 5.49 20.47 14.29 14.68 6.43 8.63 Tax Rate 0.13% 13.14% 11.22% 25.31% 16.27% 7.08% 23.57% 14.60% 18.86% 11.64% 21.77% PAT -106.42 57.37 77.94 213.97 83.67 72.05 66.39 83.58 63.14 48.83 31.01 PAT before Minority Interest -106.42 57.37 76.09 213.97 83.67 72.05 66.39 83.58 63.14 48.83 31.01 Minority Interest 0.00 0.00 1.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -10.26% 4.36% 6.57% 14.64% 6.22% 5.22% 4.91% 7.54% 9.45% 11.74% 9.03% PAT Growth -370.93% -26.39% -63.57% 155.73% 16.13% 8.53% -20.57% 32.37% 29.31% 57.47% EPS -12.84 6.92 9.40 25.81 10.09 8.69 8.01 10.08 7.62 5.89 3.74

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 572.62 567.41 560.86 369.64 373.95 374.80 346.45 345.32 153.91 123.43 Share Capital 16.50 16.50 16.20 16.20 16.20 16.20 16.06 80.93 10.16 9.96 Total Reserves 556.12 550.90 544.66 353.44 357.75 356.22 328.01 262.01 134.89 108.51 Non-Current Liabilities 243.41 288.29 296.51 549.99 465.19 422.52 281.24 162.89 101.99 165.06 Secured Loans 34.39 66.66 131.24 143.28 260.86 250.36 142.21 75.71 74.74 147.18 Unsecured Loans 55.32 49.30 57.07 49.75 46.94 40.92 41.73 53.35 0.00 0.74 Long Term Provisions 9.54 7.17 2.74 3.38 3.01 2.35 1.97 1.81 1.65 0.00 Current Liabilities 338.52 399.72 503.14 445.75 463.61 406.10 327.11 269.28 172.60 30.61 Trade Payables 35.28 23.39 45.32 24.45 45.61 39.26 46.83 27.72 6.93 21.90 Other Current Liabilities 54.01 76.77 92.03 114.08 101.66 75.08 42.67 27.16 2.93 0.04 Short Term Borrowings 214.13 258.70 305.71 291.91 291.19 276.34 225.63 202.55 152.52 0.00 Short Term Provisions 35.10 40.86 60.07 15.31 25.15 15.42 11.97 11.84 10.22 8.68 Total Liabilities 1,154.55 1,255.42 1,360.51 1,365.38 1,302.75 1,203.42 954.80 777.49 428.50 319.10 Net Block 380.70 404.83 432.93 386.94 376.55 397.33 405.08 294.50 160.02 139.08 Gross Block 474.78 480.65 503.31 495.61 466.20 464.92 454.66 327.48 185.53 159.55 Accumulated Depreciation 94.08 75.82 70.39 108.67 89.65 67.59 49.58 32.98 25.50 20.47 Non Current Assets 532.41 599.47 579.17 657.81 669.87 640.39 509.84 389.37 164.56 142.91 Capital Work in Progress 64.18 42.78 58.64 40.83 63.27 15.51 9.21 7.71 1.14 0.34 Non Current Investment 87.53 151.87 87.60 230.05 230.05 227.55 95.55 87.17 3.40 3.49 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 622.14 655.94 781.34 707.57 632.89 563.03 444.90 358.05 257.26 170.40 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 282.45 292.54 285.66 268.17 222.50 170.13 140.36 73.88 66.70 60.61 Sundry Debtors 101.89 167.67 224.85 230.86 228.07 183.79 160.06 98.72 95.96 75.32 Cash & Bank 24.96 9.18 15.55 7.18 13.99 13.26 13.67 19.41 8.63 3.41 Other Current Assets 212.86 20.28 16.92 25.63 168.32 195.84 130.81 166.05 85.97 31.07 Short Term Loans & Adv. 192.30 166.27 238.34 175.74 162.39 189.91 124.88 165.82 85.39 31.05 Net Current Assets 283.62 256.22 278.20 261.82 169.27 156.93 117.79 88.77 84.66 139.79 Total Assets 1,154.55 1,255.41 1,360.51 1,365.38 1,302.76 1,203.42 954.80 777.48 428.51 319.10

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 943.79 1,226.40 734.21 585.15 559.24 560.36 509.14 474.79 196.71 144.86 Share Capital 341.73 341.73 16.20 80.15 80.15 80.15 80.01 144.88 10.16 9.96 Total Reserves 602.07 884.67 718.01 505.00 479.09 477.84 426.77 327.54 177.68 129.94 Non-Current Liabilities 489.65 356.86 503.86 561.11 538.36 532.58 449.68 360.72 148.25 251.48 Secured Loans 369.08 275.90 396.25 206.75 436.44 378.81 255.19 258.03 131.90 234.55 Unsecured Loans 55.72 49.30 57.07 50.52 46.94 40.92 41.73 53.35 0.00 0.74 Long Term Provisions 9.21 7.03 2.19 3.57 3.17 5.16 1.47 1.06 1.69 0.00 Current Liabilities 888.93 790.23 817.39 897.41 800.86 744.42 610.73 463.69 242.44 59.38 Trade Payables 294.42 201.99 178.59 166.74 188.71 190.49 166.28 156.86 44.06 42.35 Other Current Liabilities 227.11 147.64 179.92 285.85 176.38 138.78 116.10 40.79 4.68 0.04 Short Term Borrowings 332.30 385.16 381.47 407.76 389.38 375.43 301.13 232.82 175.08 0.00 Short Term Provisions 35.10 55.43 77.41 37.06 46.39 39.71 27.22 33.21 18.61 17.00 Total Liabilities 2,322.37 2,385.77 2,055.46 2,043.67 1,898.46 1,837.36 1,569.55 1,299.20 587.40 455.72 Net Block 964.92 1,035.36 878.90 814.17 813.47 807.92 709.04 595.35 264.29 254.72 Gross Block 1,156.58 1,128.64 915.77 1,663.33 1,599.11 1,526.04 1,329.52 1,167.48 812.71 289.11 Accumulated Depreciation 191.65 93.29 36.87 849.16 785.64 718.12 620.49 572.13 548.42 34.39 Non Current Assets 1,091.77 1,103.83 961.04 911.03 906.45 846.28 736.20 604.41 266.01 255.86 Capital Work in Progress 122.31 65.27 76.13 94.17 90.28 38.12 26.92 8.37 1.73 1.14 Non Current Investment 2.51 2.70 2.71 2.69 2.70 0.24 0.24 0.70 0.00 0.00 Long Term Loans & Adv. 1.52 0.00 2.81 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,230.61 1,281.94 1,094.42 1,132.60 991.96 970.90 815.08 647.14 314.68 194.06 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 563.69 540.17 483.97 490.80 431.43 426.66 340.26 247.88 84.47 79.35 Sundry Debtors 356.11 275.43 200.14 326.24 329.58 347.83 308.23 221.61 127.56 93.86 Cash & Bank 95.30 99.03 55.47 30.96 26.67 34.57 23.96 36.34 11.10 5.62 Other Current Assets 215.51 29.59 22.53 11.73 204.28 161.84 142.64 141.32 91.55 15.23 Short Term Loans & Adv. 184.76 337.73 332.31 272.88 185.21 139.50 119.82 141.09 89.45 15.20 Net Current Assets 341.68 491.71 277.03 235.19 191.10 226.47 204.35 183.45 72.25 134.67 Total Assets 2,322.38 2,385.77 2,055.46 2,043.67 1,898.45 1,837.36 1,569.55 1,299.21 587.39 455.73

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 82.04 206.55 28.17 -54.21 41.29 -44.86 44.22 105.78 10.58 3.09 PBT 5.13 8.85 173.39 11.34 24.25 38.81 51.38 51.34 32.97 22.12 Adjustment 62.82 69.62 80.21 37.74 50.36 38.63 26.02 33.09 23.71 19.69 Changes in Working Capital 40.35 144.61 -213.96 -103.30 -33.33 -126.70 -39.12 20.70 -28.47 -24.29 Cash after chg. in Working capital 108.30 223.09 39.64 -54.21 41.29 -49.27 38.29 105.13 28.21 17.52 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -17.63 -14.44 Tax Paid -26.26 -16.54 -11.47 0.00 0.00 4.41 5.93 0.65 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 56.17 -38.12 29.83 -11.15 -50.04 -148.56 -107.67 -276.74 -81.50 8.87 Net Fixed Assets -15.53 38.52 -25.51 -6.97 -49.04 -16.56 -128.68 -148.52 -26.78 7.77 Net Investments 64.34 -64.27 142.45 0.00 -2.50 -132.00 -8.38 -83.77 0.09 -0.98 Others 7.36 -12.37 -87.11 -4.18 1.50 0.00 29.39 -44.45 -54.81 2.08 Cash from Financing Activity -123.23 -174.80 -49.62 58.54 9.48 193.01 57.71 181.73 76.15 -15.45 Net Cash Inflow / Outflow 14.98 -6.38 8.38 -6.82 0.74 -0.41 -5.74 10.77 5.23 -3.48 Opening Cash & Equivalents 9.18 15.55 7.18 13.99 13.26 13.67 19.41 8.63 3.41 6.89 Closing Cash & Equivalent 24.16 9.18 15.56 7.18 13.99 13.26 13.67 19.41 8.63 3.41

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 422.14 21.42 57.96 154.12 140.48 -117.65 90.11 45.17 23.89 55.13 PBT 66.05 85.71 286.48 99.93 77.54 86.86 97.88 77.81 55.26 39.65 Adjustment 134.05 135.90 124.15 101.94 111.32 101.31 80.43 55.16 32.30 30.82 Changes in Working Capital 237.03 -158.14 -315.94 -47.75 -48.38 -305.83 -94.13 -87.81 -63.67 5.89 Cash after chg. in Working capital 437.13 63.48 94.69 154.12 140.48 -117.65 84.18 45.17 23.89 76.36 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.99 -42.06 -36.73 0.00 0.00 0.00 5.93 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -88.87 -163.53 -68.49 -190.42 -106.71 -291.11 -169.59 -424.15 -72.39 -7.13 Net Fixed Assets -15.53 38.52 -25.51 -6.97 -49.04 -16.56 -128.68 -148.52 -26.78 7.77 Net Investments 64.34 -64.27 142.45 0.00 -2.50 -132.00 -8.38 -83.77 0.09 -0.98 Others -137.68 -137.78 -185.43 -183.45 -55.17 -142.55 -32.53 -191.86 -45.70 -13.92 Cash from Financing Activity -337.80 185.66 35.05 40.59 -41.67 419.37 67.10 404.22 53.98 -59.36 Net Cash Inflow / Outflow -4.53 43.56 24.51 4.29 -7.90 10.62 -12.38 25.24 5.47 -11.35 Opening Cash & Equivalents 99.03 55.47 30.96 26.67 34.57 23.96 36.34 11.10 5.62 16.98 Closing Cash & Equivalent 94.50 99.03 55.47 30.96 26.67 34.57 23.96 36.34 11.10 5.62

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 64.78 64.15 64.53 45.50 46.03 45.84 42.71 35.15 27.03 22.41 ROA 0.51% 0.75% 9.27% 0.61% 1.51% 2.47% 4.24% 6.70% 7.43% 5.29% ROE 1.16% 1.88% 28.34% 2.19% 5.09% 7.45% 12.50% 21.15% 22.30% 16.95% ROCE 6.22% 6.01% 22.55% 6.95% 8.74% 9.74% 11.41% 14.51% 16.10% 14.34% Fixed Asset Turnover 0.53 0.53 1.14 0.66 0.92 0.94 1.08 1.49 1.80 1.39 Receivable days 195.36 274.06 145.95 262.23 174.74 145.26 111.61 92.79 100.90 112.53 Inventory Days 416.73 403.70 177.37 280.37 166.58 131.17 92.40 67.01 75.00 95.75 Payable days 43.93 69.44 41.99 56.35 44.37 46.49 40.12 20.32 20.58 43.06 Cash Conversion Cycle 568.16 608.32 281.33 486.25 296.96 229.95 163.90 139.47 155.32 165.23 Total Debt/Equity 0.65 0.84 1.09 1.62 1.87 1.71 1.29 1.13 1.65 1.32 Interest Cover 1.10 1.17 3.94 1.19 1.36 1.80 2.62 3.13 2.79 2.44

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 70.35 104.60 85.93 64.20 61.00 58.36 52.74 42.03 35.45 26.71 ROA 2.44% 3.43% 10.44% 4.25% 3.86% 3.90% 5.83% 6.69% 9.36% 6.87% ROE 7.95% 9.76% 35.18% 16.50% 14.90% 14.81% 23.34% 26.70% 31.18% 27.74% ROCE 7.03% 9.04% 21.86% 11.93% 10.91% 11.93% 13.83% 14.29% 17.80% 16.30% Fixed Asset Turnover 1.15 1.16 1.13 0.82 0.88 0.95 0.89 0.67 0.76 1.26 Receivable days 87.64 73.20 65.71 88.94 89.58 88.63 87.21 95.35 97.13 87.46 Inventory Days 153.18 157.64 121.69 125.08 113.47 103.61 96.80 90.76 71.87 78.89 Payable days 79.66 70.90 60.76 60.42 57.00 57.11 62.91 65.22 47.96 41.69 Cash Conversion Cycle 161.15 159.93 126.64 153.61 146.05 135.14 121.10 120.89 121.04 124.66 Total Debt/Equity 1.05 0.69 1.45 1.63 1.81 1.66 1.36 1.33 1.70 1.77 Interest Cover 1.94 2.04 5.23 2.17 1.90 2.29 2.94 3.74 3.50 2.74

Top Investors:

kitara piin 1102

william f harvey

sameer mahendra sampat

tushar rameshchandra mehta

kitara piin 1101

silkon trades llp

Annual Reports:

News Update:

Vivimed Labs receives export order for supply of Favulous tablets
6th Aug 2020, 09:00 AM

Favulous tablets 200 mg is used for the treatment of mild to moderate cases of Covid-19
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback